Subtopic Deep Dive

Inherited Thrombophilias
Research Guide

What is Inherited Thrombophilias?

Inherited thrombophilias are genetic mutations such as Factor V Leiden and Prothrombin G20210A that predispose individuals to hypercoagulability and increased risk of venous thromboembolism (VTE).

These conditions include Factor V Leiden, described by Kujovich (2010) with 393 citations, and are linked to VTE risks in pregnancy and surgery. Studies like the TREATS study by Wu et al. (2006, 490 citations) assess screening cost-effectiveness in high-risk groups. Population epidemiology is detailed in Heit (2015, 1098 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

Identifying inherited thrombophilias enables personalized prophylaxis, reducing recurrent VTE in high-risk patients during pregnancy or surgery (Bates et al., 2012, 1474 citations). The TREATS study by Wu et al. (2006) shows screening benefits for women on oral contraceptives and orthopedic patients. Guidelines by Bates et al. (2018, 551 citations) guide antithrombotic therapy in pregnancy, preventing maternal morbidity.

Key Research Challenges

Screening Cost-Effectiveness

Determining when thrombophilia screening justifies costs in high-risk situations like pregnancy or surgery remains debated. Wu et al. (2006, TREATS study, 490 citations) found limited economic benefits. Population variability complicates universal guidelines.

Genotype-Phenotype Correlation

Linking specific mutations like Factor V Leiden to VTE risk varies by population and triggers. Kujovich (2010, 393 citations) reviews Factor V Leiden phenotypes. Heit (2015, 1098 citations) highlights epidemiological heterogeneity.

Pregnancy Risk Stratification

Balancing VTE prophylaxis in pregnant women with thrombophilia against bleeding risks challenges clinicians. Bates et al. (2012, 1474 citations) and Bates et al. (2018, 551 citations) provide guidelines. Individual factors like prior VTE history influence decisions.

Essential Papers

1.

Risk Factors for Venous Thromboembolism

Frederick A. Anderson, Frederick A. Spencer · 2003 · Circulation · 1.6K citations

Until the 1990s, venous thromboembolism (VTE) was viewed primarily as a complication of hospitalization for major surgery (or associated with the late stage of terminal illness). However, recent tr...

2.

VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy

Shannon M. Bates, Ian A. Greer, Saskia Middeldorp et al. · 2012 · CHEST Journal · 1.5K citations

3.

Epidemiology of venous thromboembolism

John A. Heit · 2015 · Nature Reviews Cardiology · 1.1K citations

4.

The epidemiology of venous thromboembolism

John A. Heit, Frederick A. Spencer, Richard H. White · 2016 · Journal of Thrombosis and Thrombolysis · 1.0K citations

5.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy

Shannon M. Bates, Anita Rajasekhar, Saskia Middeldorp et al. · 2018 · Blood Advances · 551 citations

Abstract Background: Venous thromboembolism (VTE) complicates ∼1.2 of every 1000 deliveries. Despite these low absolute risks, pregnancy-associated VTE is a leading cause of maternal morbidity and ...

6.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study

Olívia Wu, Lindsay Robertson, Sara Twaddle et al. · 2006 · Health Technology Assessment · 490 citations

Thrombophilia is associated with increased risks of VTE in women taking oral oestrogen preparations and patients undergoing major elective orthopaedic surgery, and of VTE and adverse pregnancy outc...

7.

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

Jeanet M. Kemmeren, A. Algra, Diederick E. Grobbee · 2001 · BMJ · 453 citations

Abstract Objective: To evaluate quantitatively articles that compared effects of second and third generation oral contraceptives on risk of venous thrombosis. Design: Meta-analysis. Studies: Cohort...

Reading Guide

Foundational Papers

Start with Anderson and Spencer (2003, 1637 citations) for VTE risk factors overview, then Kujovich (2010, 393 citations) for Factor V Leiden details, and Wu et al. (2006, 490 citations) for screening economics.

Recent Advances

Study Bates et al. (2018, 551 citations) for pregnancy guidelines, Heit (2015, 1098 citations) for epidemiology, and Lutsey and Zakai (2022, 388 citations) for prevention advances.

Core Methods

Core methods encompass genotype-phenotype studies, meta-analyses of VTE odds ratios (Kemmeren et al., 2001), cost-effectiveness modeling (Wu et al., 2006), and guideline development (Bates et al., 2012).

How PapersFlow Helps You Research Inherited Thrombophilias

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph to map thrombophilia literature from Anderson and Spencer (2003, 1637 citations), revealing clusters around VTE risk factors. exaSearch finds niche studies on Factor V Leiden, while findSimilarPapers expands from Kujovich (2010).

Analyze & Verify

Analysis Agent employs readPaperContent on Bates et al. (2012) for guideline extraction, verifyResponse with CoVe to check mutation prevalence claims against Heit (2015), and runPythonAnalysis for meta-analysis of VTE odds ratios with GRADE grading of evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in screening cost-effectiveness post-Wu et al. (2006), while Writing Agent uses latexEditText, latexSyncCitations for guideline drafts, latexCompile for PDFs, and exportMermaid for VTE risk flowcharts.

Use Cases

"Run statistical analysis on VTE odds ratios from thrombophilia screening studies."

Research Agent → searchPapers('thrombophilia screening VTE') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on extracted data) → matplotlib odds ratio plot and GRADE-scored summary.

"Draft LaTeX review on Factor V Leiden in pregnancy guidelines."

Research Agent → citationGraph(Bates 2018) → Synthesis Agent → gap detection → Writing Agent → latexEditText(draft) → latexSyncCitations → latexCompile → PDF with risk stratification table.

"Find open-source code for thrombophilia genotype simulation models."

Research Agent → paperExtractUrls(thrombophilia modeling papers) → paperFindGithubRepo → githubRepoInspect → Code Discovery workflow outputs validated Python simulators for Factor V Leiden prevalence.

Automated Workflows

Deep Research workflow conducts systematic reviews of 50+ VTE papers, chaining searchPapers → citationGraph → GRADE grading for thrombophilia guidelines like Bates et al. (2018). DeepScan's 7-step analysis verifies screening claims from Wu et al. (2006) with CoVe checkpoints. Theorizer generates hypotheses on G20210A-phenotype links from Heit (2015) epidemiology.

Frequently Asked Questions

What defines inherited thrombophilias?

Inherited thrombophilias are genetic mutations like Factor V Leiden and Prothrombin G20210A increasing VTE risk (Kujovich, 2010).

What are key screening methods?

Methods include genotype testing in high-risk groups like pregnancy or surgery; TREATS study by Wu et al. (2006) evaluates cost-effectiveness.

What are seminal papers?

Anderson and Spencer (2003, 1637 citations) on VTE risks; Bates et al. (2012, 1474 citations) on pregnancy thrombophilia.

What open problems exist?

Challenges include cost-effective screening thresholds and precise risk stratification in diverse populations (Heit, 2015; Wu et al., 2006).

Research Blood Coagulation and Thrombosis Mechanisms with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Inherited Thrombophilias with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers